The Reserve Bank of Australia has raised its cash rate for the first time since 2022, signaling a shift in policy as the economy outperforms expectations and inflation proves more persistent than forecast.
Market analysts have significantly raised their revenue and earnings forecasts for Impala Platinum Holdings, projecting a sharp recovery and growth rate that outpaces the broader mining sector.
Shares of CTI Logistics Limited (ASX:CLX) have climbed 25% in the past three months, prompting a closer look at the company's fundamentals. While its Return on Equity appears modest, exceptional earnings growth and a consistent dividend history suggest underlying strength.
Despite a modest rise in annual revenue, Mudajaya Group Berhad (KLSE:MUDAJYA) has seen its share price plummet 65% over five years, leaving long-term investors deep in the red. We examine the disconnect between business performance and market sentiment.
New industry figures show a surprising 30% surge in fixed-lens camera shipments, fueling overall market growth while DSLR sales continue their steep decline.
A tentative détente between the U.S. and Iran is injecting optimism into Gulf markets, with bourses in Saudi Arabia and Dubai rallying. Against this backdrop, investors are scouring the region for fundamentally strong companies poised to capitalize on the shifting landscape.
A notable easing of US-Iran tensions has buoyed investor confidence across Gulf bourses, creating a favorable backdrop for stable, income-generating equities. We analyze three regional dividend stocks offering potential portfolio resilience amid shifting market dynamics.
Tesla has quietly added a new all-wheel-drive configuration to its popular Model Y SUV in the United States, positioned as a mid-tier option priced at $41,990. The move continues the automaker's recent strategy of broadening its lineup with more accessible price points.
The Federal Reserve's decision to hold interest rates steady has exposed a deepening policy divide, with one governor publicly warning that inaction risks a significant deterioration in the jobs landscape.
As income investors look toward 2026, a stark choice emerges between Energy Transfer's tempting 7.1% yield and Enterprise Products Partners' quarter-century record of reliable payouts. We examine the risk-reward calculus behind the numbers.
As PTC prepares to release its Q4 financial results, investors are weighing its strong historical performance against a turbulent market for vertical software stocks. Here’s the breakdown.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Tenable Holdings, a leader in exposure management, reports its fourth-quarter earnings after the bell Wednesday. All eyes will be on whether the company can maintain its track record of revenue beats against a backdrop of slowing growth forecasts and a battered cybersecurity sector.
Samsung Electronics unveils enhanced privacy controls for Galaxy devices and a special Olympic Edition of its foldable phone, aiming to bolster its brand in security and high-profile partnerships while its shares show significant long-term gains.
Shares of Coastal Financial (CCB) have tumbled over 13% in the past month, sparking debate among investors. While a proprietary valuation model suggests the stock is deeply undervalued, its premium P/E ratio tells a conflicting story. We examine the numbers and the broader context for regional banks.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
Compass Point Research suggests the prolonged cryptocurrency downturn may be nearing its end, with Bitcoin finding a potential bottom around $60,000-$68,000 unless broader market turmoil intervenes.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
Offshore drilling contractor Noble Corporation bolsters its forward workload with a series of new multi-year contracts totaling approximately $1.3 billion, headlined by a major harsh-environment rig award in Norway, signaling a strategic geographic expansion and renewed confidence in the offshore cycle.
